Reactivation of histoplasmosis after treatment with infliximab.
Nakelchik
Masha
M
Mangino
Julie E
JE
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D005260:Female; D006660:Histoplasmosis / Q000175:diagnosis / Q000209:etiology*; D006801:Humans; D000069285:Infliximab; D008875:Middle Aged; D012008:Recurrence; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab